Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TROPOS trial of tralokinumab for oral corticosteroid reduction in corticosteroid-dependent asthma
2014-001391-54Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Tralokinumab with Placebo (2 arms). Primary endpoint: Percent change from baseline in daily average oral corticosteroid dose at Week 40 without loss of asthma control. Started Nov 2014; status: completed.
02
Drugs
tralokinumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2014-001391-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001391-54.